Emerging restorative treatments for parkinson's disease: Manipulation and inducement of dopaminergic neurons from adult stem cells

CNS and Neurological Disorders - Drug Targets

Volumn 10, Issue 4, 2011, Pages 509-516

  Zhao, Junpeng ^a   Xu, Qunyuan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Adult stem cells; Carotid body stem cells; Dopaminergic neurons; Embryonic stem cells; Induced pluripotent stem cells; Mesenchymal stem cells; Neural stem cells; Parkinson's disease

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP; DOPAMINE; FIBROBLAST GROWTH FACTOR 8; GLIAL FIBRILLARY ACIDIC PROTEIN; HEPATOCYTE NUCLEAR FACTOR 3BETA; KRUPPEL LIKE FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 4; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR SOX2; TYROSINE 3 MONOOXYGENASE; WNT1 PROTEIN;

ADULT STEM CELL; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW; BRAIN ELECTROPHYSIOLOGY; CANCER INHIBITION; CARCINOGENICITY; CAROTID BODY; CAROTID BODY STEM CELL; CAUDATE NUCLEUS; CELL CYCLE PROGRESSION; CELL FUNCTION; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL THERAPY; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; DOPAMINERGIC NERVE CELL; EMBRYONIC STEM CELL; FETAL STEM CELL; FIBROBLAST; GENE LOCUS; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MESENCEPHALON; MESENCHYMAL STEM CELL; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NEUROPROTECTION; NONHUMAN; ONCOGENE C MYC; PARKINSON DISEASE; PLURIPOTENT STEM CELL; SIGNAL TRANSDUCTION; STEM CELL; SUBSTANTIA NIGRA;

EID: 79956269136     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/187152711795563921     Document Type: Article

References (73)

1. Deierborg, T.; Soulet, D.; Roybon, L.; Hall, V.; Brundin, P. Emerging restorative treatments for Parkinson's disease. Prog. Neurobiol., 2008, 85(4), 407-432.
2. Dunnett, S.B.; Bjorklund, A. Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature, 1999, 399(6738 Suppl), A32-A39.
3. Bjorklund, L.M.; Sanchez-Pernaute, R.; Chung, S.; Andersson, T.; Chen, I.Y.; McNaught, K.S.; Brownell, A.L.; Jenkins, B.G.; Wahlestedt, C.; Kim, K.S.; Isacson, O. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl. Acad. Sci. USA, 2002, 99(4), 2344-2349.
4. Srivastava, A.S.; Malhotra, R.; Sharp, J.; Berggren, T. Potentials of ES cell therapy in neurodegenerative diseases. Curr. Pharm. Des., 2008, 14(36), 3873-3879.
5. Kim, J.H.; Auerbach, J.M.; Rodriguez-Gomez, J.A.; Velasco, I.; Gavin, D.; Lumelsky, N.; Lee, S.H.; Nguyen, J.; Sanchez-Pernaute, R.; Bankiewicz, K.; McKay, R. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature, 2002, 418(6893), 50-56.
6. Sanchez-Pernaute, R.; Lee, H.; Patterson, M.; Reske-Nielsen, C.; Yoshizaki, T.; Sonntag, K.C.; Studer, L.; Isacson, O. Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease. Brain, 2008, 131(Pt8), 2127-2139.
7. Lindv all, O.; Brundin, P.; Widner, H.; Rehncrona, S.; Gustavii, B.; Frackowiak, R.; Leenders, K.L.; Sawle, G.; Rothwell, J.C.; Marsden, C.D. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science, 1990, 247(4942), 574-577.
8. Smith, R.; Bagga, V.; Fricker-Gates, R.A. Embryonic neural progenitor cells: the effects of species, region, and culture conditions on long-term proliferation and neuronal differentiation. J. Hematother. Stem Cell Res., 2003, 12(6), 713-725.
9. Ostenfeld, T.; Svendsen, C.N. Requirement for neurogenesis to proceed through the division of neuronal progenitors following differentiation of epidermal growth factor and fibroblast growth factor-2-responsive human neural stem cells. Stem Cells, 2004, 22(5), 798-811.
10. Jonsson, M.E.; Ono, Y.; Bjorklund, A.; Thompson, L.H. Identification of transplantable dopamine neuron precursors at different stages of midbrain neurogenesis. Exp. Neurol., 2009, 219(1), 341-354.
11. Jiang, Y.; Jahagirdar, B.N.; Reinhardt, R.L.; Schwartz, R.E.; Keene, C.D.; Ortiz-Gonzalez, X.R.; Reyes, M.; Lenvik, T.; Lund, T.; Blackstad, M.; Du, J.; Aldrich, S.; Lisberg, A.; Low, W.C.; Largaespada, D.A.; Verfaillie, C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 2002, 418(6893), 41-49.
12. Ishikawa, F.; Shimazu, H.; Shultz, L.D.; Fukata, M.; Nakamura, R.; Lyons, B.; Shimoda, K.; Shimoda, S.; Kanemaru, T.; Nakamura, K.; Ito, H.; Kaji, Y.; Perry, A.C.; Harada, M. Purified human hematopoietic stem cells contribute to the generation of cardiomyocytes through cell fusion. FASEB J., 2006, 20(7), 950-952.
13. Campagnoli, C.; Roberts, I.A.; Kumar, S.; Bennett, P.R.; Bellantuono, I.; Fisk, N.M. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood, 2001, 98(8), 2396-2402.
14. Seo, M.S.; Jeong, Y.H.; Park, J.R.; Park, S.B.; Rho, K.H.; Kim, H.S.; Yu, K.R.; Lee, S.H.; Jung, J.W.; Lee, Y.S.; Kang, K.S. Isolation and characterization of canine umbilical cord bloodderived mesenchymal stem cells. J. Vet. Sci., 2009, 10(3), 181-187.
15. Gronthos, S.; Franklin, D.M.; Leddy, H.A.; Robey, P.G.; Storms, R.W.; Gimble, J.M. Surface protein characterization of human adipose tissue-derived stromal cells. J. Cell Physiol., 2001, 189(1), 54-63.
16. Ohgushi, H.; Caplan, A.I. Stem cell technology and bioceramics: from cell to gene engineering. J. Biomed. Mater. Res., 1999, 48(6), 913-927.
17. Fu, Y.S.; Cheng, Y.C.; Lin, M.Y.; Cheng, H.; Chu, P.M.; Chou, S.C.; Shih, Y.H.; Ko, M.H.; Sung, M.S. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells, 2006, 24(1), 115-124.
18. Kadam, S.S.; Tiwari, S.; Bhonde, R.R. Simultaneous isolation of vascular endothelial cells and mesenchymal stem cells from the human umbilical cord. Invitro Cell Dev. Biol. Anim., 2009, 45(1-2), 23-27.
19. Liu, B.F.; Gao, E.J.; Zeng, X.Z.; Ji, M.; Cai, Q.; Lu, Q.; Yang, H.; Xu, Q.Y. Proliferation of neural precursors in the subventricular zone after chemical lesions of the nigrostriatal pathway in rat brain. Brain Res., 2006, 1106(1), 30-39.
20. Arias-Carrion, O.; Yuan, T.F. Autologous neural stem cell transplantation: a new treatment option for Parkinson's disease? Med. Hypotheses, 2009, 73(5), 757-759.
21. Gronthos, S.; Zannettino, A.C.; Hay, S.J.; Shi, S.; Graves, S.E.; Kortesidis, A.; Simmons, P.J. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J. Cell Sci., 2003, 116(Pt9), 1827-1835.
22. Trzaska, K.A.; King, C.C.; Li, K.Y.; Kuzhikandathil, E.V.; Nowycky, M.C.; Ye, J.H.; Rameshwar, P. Brain-derived neurotrophic factor facilitates maturation of mesenchymal stem cell-derived dopamine progenitors to functional neurons. J. Neurochem., 2009, 110(3), 1058-1069.
23. Trzaska, K.A.; Kuzhikandathil, E.V.; Rameshwar, P. Specification of a dopaminergic phenotype from adult human mesenchymal stem cells. Stem Cells, 2007, 25(11), 2797-2808.
24. Lopez-Barneo, J.; Ortega-Saenz, P.; Pardal, R.; Pascual, A.; Piruat, J.I. Carotid body oxygen sensing. Eur. Respir. J., 2008, 32(5), 1386-1398.
25. Pardal, R.; Ortega-Saenz, P.; Duran, R.; Lopez-B arneo, J. Glia-like stem cells sustain physiologic neurogenesis in the adult mammalian carotid body. Cell, 2007, 131(2), 364-377.
26. Nurse, C.A. Neurotransmission and neuromodulation in the chemosensory carotid body. Auton. Neurosci., 2005, 120(1-2), 1-9.
27. Leitner, M.L.; Wang, L.H.; Osborne, P.A.; Golden, J.P.; Milbrandt, J.; Johnson, E.M., Jr. Expression and function of GDNF family ligands and receptors in the carotid body. Exp. Neurol., 2005, 191(Suppl 1), S68-S79.
28. Redmond, D.E., Jr.; Elsworth, J D.; Roth, R.H.; Leranth, C.; Collier, T.J.; Blanchard, B.; Bjugstad, K.B.; Samulski, R.J.; Aebischer, P.; Sladek, J.R., Jr. Embryonic substantia nigra grafts in the mesencephalon send neurites to the host striatum in non-human primate after overexpression of GDNF. J. Comp. Neurol., 2009, 515(1), 31-40.
29. Villadiego, J.; Mendez-Ferrer, S.; Valdes-Sanchez, T.; Silos- Santiago, I.; Farinas, I.; Lopez-Barneo, J.; Toledo-Aral, J.J. Selective glial cell line-derived neurotrophic factor production in adult dopaminergic carotid body cells in situ and after intrastriatal transplantation. J. Neurosci., 2005, 25(16), 4091-4098.
30. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126(4), 663-676.
31. Okita, K.; Ichisaka, T.; Yamanaka, S. Generation of germlinecompetent induced pluripotent stem cells. Nature, 2007, 448(7151), 313-317.
32. Pan, G.J.; Chang, Z.Y.; Scholer, H.R.; Pei, D. Stem cell pluripotency and transcription factor Oct4. Cell Res., 2002, 12(5-6), 321-329.
33. Masui, S.; Nakatake, Y.; Toyooka, Y.; Shimosato, D.; Yagi, R.; Takahashi, K.; Okochi, H.; Okuda, A.; Matoba, R.; Sharov, A.A.; Ko, M.S.; Niwa, H. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol., 2007, 9(6), 625-635.
34. Zhao, X.Y.; Li, W., Lv, Z.; Liu, L.; Tong, M.; Hai, T.; Hao, J.; Guo, C.L.; Ma, Q.W.; Wang, L.; Zeng, F.; Zhou, Q. iPS cells produce viable mice through tetraploid complementation. Nature, 2009, 461(7260), 86-90.
35. Westerlund, U.; Svensso n, M.; Moe, M.C.; Varghese, M.; Gustavsson, B.; Wallstedt, L.; Berg-Johnsen, J.; Langmoen, I.A. Endoscopically harvested stem cells: a putative method in future autotransplantation. Neurosurgery, 2005, 57(4), 779-784.
36. Bjugstad, K.B.; Teng, Y.D.; Redmond, D.E., Jr.; Elsworth, J.D.; Roth, R.H.; Cornelius, S.K.; Snyder, E.Y.; Sladek, J.R., Jr. Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease. Exp. Neurol., 2008, 211(2), 362-369.
37. Geeta, R.; Ramnath, R.L.; Rao, H.S.; Chandra, V. One year survival and significant reversal of motor deficits in parkinsonian rats transplanted with hESC derived dopaminergic neurons. Biochem. Biophys. Res. Commun., 2008, 373(2), 258-264.
38. Brustle, O.; Spiro, A.C.; Karram, K.; Choudhary, K.; Okabe, S.; McKay, R.D. In vitro-generated neural precursors participate in mammalian brain development. Proc. Natl. Acad. Sci. USA, 1997, 94(26), 14809-14814.
39. Deacon, T.; Dinsmore, J.; Costantini, L.C.; Ratliff, J.; Isacson, O. Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation. Exp. Neurol., 1998, 149(1), 28-41.
40. Blandini, F.; Cova, L.; Armentero, M.T.; Zennaro, E.; Levandis, G.; Bossolasco, P.; Calzarossa, C.; Mellone, M.; Giuseppe, B.; Deliliers, G.L.; Polli, E.; Nappi, G.; Silani, V. Transplantation of undifferentiated human mesenchymal stem cells protects against 6- hydroxydopamine neurotoxicity in the rat. Cell Transplant., 2010, 19(2), 203-217.
41. Belzunegui, S.; Izal-Azcarate, A.; San Sebastian, W.; Garrido-Gil, P.; Vazquez-Claverie, M.; Lopez, B.; Marcilla, I.; Luquin, M.R. Striatal carotid body graft promotes differentiation of neural progenitor cells into neurons in the olfactory bulb of adult hemiparkisonian rats. Brain Res., 2008, 1217, 213-220.
42. Cova, L.; Armentero, M.T.; Zennaro, E.; Calzarossa, C.; Bossolasco, P.; Busca, G.; Lambertenghi, D.G.; Polli, E.; Nappi, G.; Silani, V.; Blandini, F. Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease. Brain Res., 2010, 1311, 12-27.
43. Wernig, M.; Zhao, J.P.; Pruszak, J.; Hedlund, E.; Fu, D.; Soldner, F.; Broccoli, V.; Constantine-Paton, M.; Isacson, O.; Jaenisch, R. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. USA, 2008, 105(15), 5856-5861.
44. Park, I.H.; Arora, N.; Huo, H.; Maherali, N.; Ahfeldt, T.; Shimamura, A.; Lensch, M.W.; Cowan, C.; Hochedlinger, K.; Daley, G.Q. Disease-specific induced pluripotent stem cells. Cell, 2008, 134(5), 877-886.
45. Wichterle, H.; Przedborski, S. What can pluripotent stem cells teach us about neurodegenerative diseases? Nat. Neurosci., 2010, 13(7), 800-804.
46. Hargus, G.; Cooper, O.; Deleidi, M.; Levy, A.; Lee, K.; Marlow, E.; Yow, A.; Soldner, F.; Hockemeyer, D.; Hallett, P.J.; Osborn, T.; Jaenisch, R.; Isacson, O. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc. Natl. cad. Sci. USA, 2010, 107(36), 15921-15926.
47. Rowland, B.D.; Bernards, R.; Peeper, D.S. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat. Cell Biol., 2005, 7(11), 1074-1082.
48. Doi, A.; Park, I.H.; Wen, B.; Murakami, P.; Aryee, M.J.; Irizarry, R.; Herb, B.; Ladd-Acosta, C.; Rho, J.; Loewer, S.; Miller, J.; Schlaeger, T.; Daley, G.Q.; Feinberg, A.P. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat. Genet., 2009, 41(12), 1350-1353.
49. Meyer, A.K.; Maisel, M.; Hermann, A.; Stirl, K.; Storch, A. Restorative approaches in Parkinson's Disease: which cell type wins the race? J. Neurol. Sci., 2010, 289(1-2), 93-103.
50. Sanchez-Ramos, J.; Song, S.; Cardozo-Pelaez, F.; Hazzi, C.; Stedeford, T.; Willing, A.; Freeman, T.B.; Saporta, S.; Janssen, W.; Patel, N.; Cooper, D.R.; Sanberg, P.R. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp. Neurol., 2000, 164(2), 247-256.
51. Woodbury, D.; Sc hwarz, E.J.; Prockop, D.J.; Black, I.B. Adult ratand human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res., 2000, 61(4), 364-370.
52. Jin, G.Z.; Cho, S.J.; Choi, E.G.; Lee, Y.S.; Yu, X.F.; Choi, K.S.; Yee, S.T.; Jeon, J.T.; Kim, M.O.; Kong, I.K. Rat mesenchymal stem cells increase tyrosine hydroxylase expression and dopamine content in ventral mesencephalic cells in vitro. Cell Biol. Int., 2008, 32(11), 1433-1438.
53. Levy, Y.S.; Bahat-Stroomza, M.; Barzilay, R.; Burshtein, A.; Bulvik, S.; Barhum, Y.; Panet, H.; Melamed, E.; Offen, D. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease. Cytotherapy, 2008, 10(4), 340-352.
54. Minguez-Castellanos, A.; Escamilla-Sevilla, F.; Hotton, G.R.; Toledo-Aral, J.J.; Ortega-Moreno, A.; Mendez-Ferrer, S.; Martin-Linares, J.M.; Katati, M.J.; Mir, P.; Villadiego, J.; Meersmans, M.; Perez-Garcia, M.; Brooks, D.J.; Arjona, V.; Lopez-Barneo, J. Carotid body autotransplantation in Parkinson disease: a clinical and positron emission tomography study. J. Neurol. Neurosurg. Psychiatry, 2007, 78(8), 825-831.
55. Ye, W.; Shimamura, K.; Rubenstein, J.L.; Hynes, M.A.; Rosenthal, A. FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell, 1998, 93(5), 755-766.
56. Rossler, R.; Copray, S.; Boddeke, E. Differentiation of nonmesencephalic neural stem cells towards dopaminergic neurons. Neuroscience, 2010, 170(2), 417-428.
57. Cooper, O.; Hargus, G.; Deleidi, M.; Blak, A.; Osborn, T.; Marlow, E.; Lee, K.; Levy, A.; Perez-Torres, E.; Yow, A.; Isacson, O. Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid. Mol. Cell Neurosci., 2010, 45(3), 258-266.
58. Colleoni, S.; Galli, C.; Giannelli, S.G.; Armentero, M.T.; Blandini, F.; Broccoli, V.; Lazzari, G. Long-term culture and differentiation of CNS precursors derived from anterior human neural rosettes following exposure to ventralizing factors. Exp. Cell Res., 2010, 316(7), 1148-1158.
59. Denham, M.; Thompson, L.H.; Leung, J.; Pebay, A.; Bjorklund, A.; Dottori, M. Gli1 is an inducing factor in generating floor plate progenitor cells from human embryonic stem cells. Stem Cells, 2010, 28(10), 1805-1815.
60. Ono, Y.; Nakatani, T.; Minaki, Y.; Kumai, M. The basic helixloop- helix transcription factor Nato3 controls neurogenic activity in mesencephalic floor plate cells. Development, 2010, 137(11), 1897-1906.
61. Tang, M.; Villaescusa, J.C.; Luo, S.X.; Guitarte, C.; Lei, S.; Miyamoto, Y.; Taketo, M.M.; Arenas, E.; Huang, E.J. Interactions of Wnt/beta-catenin signaling and sonic hedgehog regulate the neurogenesis of ventral midbrain dopamine neurons. J. Neurosci., 2010, 30(27), 9280-9291.
62. Saucedo-Cardenas, O.; Quintana-Hau, J.D.; Le, W.D.; Smidt, M.P.; Cox, J.J.; De Mayo, F.; Burbach, J.P.; Conneely, O.M. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl. Acad. Sci. USA, 1998, 95(7), 4013-4018.
63. Konstantoulas, C.J.; Parmar, M.; Li, M. FoxP1 promotes midbrain identity in embryonic stem cell-derived dopamine neurons by regulating Pitx3. J. Neurochem., 2010, 113(4), 836-847.
64. Colter, D.C.; Sekiya, I.; Prockop, D.J. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc. Natl. Acad. Sci. USA, 2001, 98(14), 7841-7845.
65. Maisel, M.; Habisch, H J.; Royer, L.; Herr, A.; Milosevic, J.; Hermann, A.; Liebau, S.; Brenner, R.; Schwarz, J.; Schroeder, M.; Storch, A. Genome-wide expression profiling and functional network analysis upon neuroectodermal conversion of human mesenchymal stem cells suggest HIF-1 and miR-124a as important regulators. Exp. Cell Res., 2010, 316(17), 2760-2778.
66. Zhang, L.; Seitz, L.C.; Abramczyk, A.M.; Liu, L.; Chan, C. cAMP initiates early phase neuron-like morphology changes and late phase neural differentiation in mesenchymal stem cells. Cell Mol. Life Sci., 2011, 68(5), 863-876.
67. Wang, Z.Y.; Bisgard, G.E. Chronic hypoxia-induced morphological and neurochemical changes in the carotid body. Microsc. Res. Tech., 2002, 59(3), 168-177.
68. Jin, G.Z.; Yin, X.J.; Yu, X.F.; Cho, S.J.; Lee, H.S.; Lee, H.J.; Kong, I.K. Enhanced tyrosine hydroxylase expression in PC12 cells co-cultured with feline mesenchymal stem cells. J. Vet. Sci., 2007, 8(4), 377-382.
69. Zhu, Q.; Ma, J.; Yu, L.; Yuan, C. Grafted neural stem cells migrate to substantia nigra and improve behavior in Parkinsonian rats. Neurosci. Lett., 2009, 462(3), 213-218.
70. Zou, Z.; Jiang, X.; Zhang, W.; Zhou, Y.; Ke, Y.; Zhang, S.; Xu, R. Efficacy of Tyrosine Hydroxylase gene modified neural stem cells derived from bone marrow on Parkinson's disease--a rat model study. Brain Res., 2010, 1346, 279-286.
71. Judenhofer, M.S.; Wehrl, H.F.; Newport, D.F.; Catana, C.; Siegel, S.B.; Becker, M.; Thielscher, A.; Kneilling, M.; Lichy, M.P.; Eichner, M.; Klingel, K.; Reischl, G.; Widmaier, S.; Rocken, M.; Nutt, R.E.; Machulla, H.J.; Uludag, K.; Cherry, S.R.; Claussen, C.D.; Pichler, B.J. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat. Med., 2008, 14(4), 459-465.
72. Li, J.Y.; Englund, E.; Holton, J.L.; Soulet, D.; Hagell, P.; Lees, A.J.; Lashley, T.; Quinn, N.P.; Rehncrona, S.; Bjorklund, A.; Widner, H.; Revesz, T.; Lindvall, O.; Brundin, P. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest hostto-graft disease propagation. Nat. Med., 2008, 14(5), 501-503.
73. Kordower, J.H.; Chu, Y.; Hauser, R.A.; Freeman, T.B.; Olanow, C.W. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat. Med., 2008, 14(5), 504-506.